Klaus Pietzner
Overview
Explore the profile of Klaus Pietzner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Armbrust R, Fotopoulou C, Zocholl D, Chekerov R, Muallem M, Braicu I, et al.
Int J Gynecol Cancer
. 2025 Mar;
:101683.
PMID: 40057416
Objective: The phase III LION trial found no therapeutic benefit from systematic lymphadenectomy in patients with advanced ovarian cancer with optimal upfront cytoreduction and normal-appearing lymph nodes. Patients were randomized...
2.
Riedel M, Herrmann H, Bartl T, Rossner A, Tatzber A, Flethe C, et al.
BMC Cancer
. 2025 Jan;
25(1):170.
PMID: 39881252
Background: The integration of immune checkpoint inhibitors (ICIs) into routine gynecologic cancer treatment requires a thorough understanding of how to manage immune-related adverse events (irAEs) to ensure patient safety. However,...
3.
von Waldenfels G, Beck M, Semmler J, Gerber A, Hennigs A, Vochem R, et al.
Arch Gynecol Obstet
. 2024 Apr;
309(6):2771-2778.
PMID: 38625545
Purpose: The primary objective of this study was to establish a benchmark by collecting baseline data on surgical education in obstetrics and gynecology in Germany, including factual number of operations...
4.
Alwafai Z, Beck M, Fazeli S, Gurtler K, Kunz C, Singhartinger J, et al.
BMC Cancer
. 2024 Apr;
24(1):413.
PMID: 38570755
No abstract available.
5.
Alwafai Z, Beck M, Fazeli S, Gurtler K, Kunz C, Singhartinger J, et al.
BMC Cancer
. 2024 Mar;
24(1):380.
PMID: 38528468
Background: Accurate preoperative molecular and histological risk stratification is essential for effective treatment planning in endometrial cancer. However, inconsistencies between pre- and postoperative tumor histology have been reported in previous...
6.
Krankenberg D, Muallem M, Pietzner K, Chekerov R, Armbrust R, Beteta C, et al.
Arch Gynecol Obstet
. 2024 Mar;
309(6):2821-2828.
PMID: 38507090
Purpose: With growing knowledge about ovarian cancer over the last decades, diagnosis, evaluation and treatment of ovarian cancer patients have become highly specialized, and an individually adapted approach should be...
7.
Balint N, Woopen H, Richter R, Pirmorady-Sehouli A, Pietzner K, Sehouli J
Cancers (Basel)
. 2024 Feb;
16(4).
PMID: 38398202
Background: The aim of this study was to analyze the associations between sexuality, quality of life, treatment discontinuation, and survival in recurrent ovarian cancer (OC). Methods: Raw data from various...
8.
Herzog E, Pirmorady Sehouli A, Boer J, Pietzner K, Petru E, Heinzelmann V, et al.
Int J Gynecol Cancer
. 2023 Dec;
33(12):1934-1942.
PMID: 38052472
Background: Delivering bad news to patients is one of the most challenging tasks in medical practice. Despite its great relevance to patients, relatives, and medical staff, there is a paucity...
9.
Middel C, Stetzuhn M, Sander N, Kalkbrenner B, Tigges T, Pielmus A, et al.
Intensive Care Med Exp
. 2023 Sep;
11(1):61.
PMID: 37682496
Background: Patients undergoing high-risk surgery show haemodynamic instability and an increased risk of morbidity. However, most of the available data concentrate on the intraoperative period. This study aims to characterise...
10.
Maurer M, Staudacher J, Meyer R, Maurer I, Lazaridis L, Muther M, et al.
J Cancer Res Clin Oncol
. 2023 Jun;
149(12):10075-10084.
PMID: 37261525
Purpose: Modern, personalized treatment concepts in oncology require an interdisciplinary and multiprofessional collaboration. In addition to its relevance in patient care, interdisciplinary collaboration is also becoming increasingly important in clinical...